vs

Side-by-side financial comparison of FTAI Infrastructure Inc. (FIP) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

FTAI Infrastructure Inc. is the larger business by last-quarter revenue ($143.5M vs $74.7M, roughly 1.9× Health Catalyst, Inc.). FTAI Infrastructure Inc. runs the higher net margin — -68.1% vs -121.9%, a 53.8% gap on every dollar of revenue. On growth, FTAI Infrastructure Inc. posted the faster year-over-year revenue change (77.7% vs -6.2%). Health Catalyst, Inc. produced more free cash flow last quarter ($9.6M vs $-68.6M). Over the past eight quarters, FTAI Infrastructure Inc.'s revenue compounded faster (31.9% CAGR vs -0.0%).

FTAI Infrastructure Inc. owns, operates and invests in high-quality critical infrastructure assets across core sectors including transportation logistics, midstream energy, and power generation. It primarily serves North American markets, focusing on assets with stable long-term cash flows, contracted revenue streams, and strong market positions to deliver sustainable returns for stakeholders.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

FIP vs HCAT — Head-to-Head

Bigger by revenue
FIP
FIP
1.9× larger
FIP
$143.5M
$74.7M
HCAT
Growing faster (revenue YoY)
FIP
FIP
+83.9% gap
FIP
77.7%
-6.2%
HCAT
Higher net margin
FIP
FIP
53.8% more per $
FIP
-68.1%
-121.9%
HCAT
More free cash flow
HCAT
HCAT
$78.3M more FCF
HCAT
$9.6M
$-68.6M
FIP
Faster 2-yr revenue CAGR
FIP
FIP
Annualised
FIP
31.9%
-0.0%
HCAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FIP
FIP
HCAT
HCAT
Revenue
$143.5M
$74.7M
Net Profit
$-97.7M
$-91.0M
Gross Margin
Operating Margin
-45.7%
-115.3%
Net Margin
-68.1%
-121.9%
Revenue YoY
77.7%
-6.2%
Net Profit YoY
21.6%
-340.3%
EPS (diluted)
$-1.04
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FIP
FIP
HCAT
HCAT
Q4 25
$143.5M
$74.7M
Q3 25
$140.6M
$76.3M
Q2 25
$122.3M
$80.7M
Q1 25
$96.2M
$79.4M
Q4 24
$80.8M
$79.6M
Q3 24
$83.3M
$76.4M
Q2 24
$84.9M
$75.9M
Q1 24
$82.5M
$74.7M
Net Profit
FIP
FIP
HCAT
HCAT
Q4 25
$-97.7M
$-91.0M
Q3 25
$-104.5M
$-22.2M
Q2 25
$-70.0M
$-41.0M
Q1 25
$120.2M
$-23.7M
Q4 24
$-124.7M
$-20.7M
Q3 24
$-43.0M
$-14.7M
Q2 24
$-48.1M
$-13.5M
Q1 24
$-50.3M
$-20.6M
Gross Margin
FIP
FIP
HCAT
HCAT
Q4 25
Q3 25
52.6%
Q2 25
Q1 25
Q4 24
Q3 24
47.5%
Q2 24
Q1 24
Operating Margin
FIP
FIP
HCAT
HCAT
Q4 25
-45.7%
-115.3%
Q3 25
-70.8%
-22.9%
Q2 25
-56.4%
-46.0%
Q1 25
81.8%
-25.4%
Q4 24
-152.7%
-22.0%
Q3 24
-51.7%
-17.9%
Q2 24
-56.4%
-20.8%
Q1 24
-58.8%
-30.5%
Net Margin
FIP
FIP
HCAT
HCAT
Q4 25
-68.1%
-121.9%
Q3 25
-74.4%
-29.1%
Q2 25
-57.2%
-50.8%
Q1 25
125.0%
-29.9%
Q4 24
-154.4%
-26.0%
Q3 24
-51.6%
-19.3%
Q2 24
-56.7%
-17.8%
Q1 24
-60.9%
-27.6%
EPS (diluted)
FIP
FIP
HCAT
HCAT
Q4 25
$-1.04
$-1.29
Q3 25
$-1.38
$-0.32
Q2 25
$-0.73
$-0.59
Q1 25
$0.89
$-0.35
Q4 24
$-1.21
$-0.33
Q3 24
$-0.45
$-0.24
Q2 24
$-0.52
$-0.23
Q1 24
$-0.54
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FIP
FIP
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$57.4M
$95.7M
Total DebtLower is stronger
$3.8B
$153.3M
Stockholders' EquityBook value
$21.3M
$245.8M
Total Assets
$5.7B
$502.6M
Debt / EquityLower = less leverage
176.99×
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FIP
FIP
HCAT
HCAT
Q4 25
$57.4M
$95.7M
Q3 25
$34.7M
$91.5M
Q2 25
$33.6M
$97.3M
Q1 25
$26.3M
$342.0M
Q4 24
$27.8M
$392.0M
Q3 24
$20.3M
$387.3M
Q2 24
$33.1M
$308.3M
Q1 24
$23.0M
$327.8M
Total Debt
FIP
FIP
HCAT
HCAT
Q4 25
$3.8B
$153.3M
Q3 25
$3.7B
$153.1M
Q2 25
$3.1B
$153.0M
Q1 25
$2.8B
$382.9M
Q4 24
$1.6B
$382.4M
Q3 24
$1.5B
$345.0M
Q2 24
$1.6B
Q1 24
$1.3B
Stockholders' Equity
FIP
FIP
HCAT
HCAT
Q4 25
$21.3M
$245.8M
Q3 25
$181.1M
$331.9M
Q2 25
$375.5M
$347.5M
Q1 25
$476.2M
$376.8M
Q4 24
$202.7M
$365.2M
Q3 24
$370.8M
$355.0M
Q2 24
$394.8M
$357.0M
Q1 24
$402.5M
$357.2M
Total Assets
FIP
FIP
HCAT
HCAT
Q4 25
$5.7B
$502.6M
Q3 25
$5.5B
$587.1M
Q2 25
$4.4B
$616.2M
Q1 25
$4.1B
$891.5M
Q4 24
$2.4B
$858.9M
Q3 24
$2.4B
$813.0M
Q2 24
$2.5B
$691.7M
Q1 24
$2.3B
$695.1M
Debt / Equity
FIP
FIP
HCAT
HCAT
Q4 25
176.99×
0.62×
Q3 25
20.59×
0.46×
Q2 25
8.21×
0.44×
Q1 25
5.79×
1.02×
Q4 24
7.84×
1.05×
Q3 24
4.14×
0.97×
Q2 24
3.94×
Q1 24
3.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FIP
FIP
HCAT
HCAT
Operating Cash FlowLast quarter
$-2.8M
$9.9M
Free Cash FlowOCF − Capex
$-68.6M
$9.6M
FCF MarginFCF / Revenue
-47.8%
12.9%
Capex IntensityCapex / Revenue
45.9%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-398.5M
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FIP
FIP
HCAT
HCAT
Q4 25
$-2.8M
$9.9M
Q3 25
$-24.4M
$-464.0K
Q2 25
$-5.2M
$-9.0M
Q1 25
$-85.7M
$280.0K
Q4 24
$-8.1M
$-3.5M
Q3 24
$14.2M
$6.2M
Q2 24
$-17.6M
$1.6M
Q1 24
$-3.9M
$10.3M
Free Cash Flow
FIP
FIP
HCAT
HCAT
Q4 25
$-68.6M
$9.6M
Q3 25
$-90.7M
$-719.0K
Q2 25
$-87.5M
$-9.2M
Q1 25
$-151.7M
$-390.0K
Q4 24
$-34.3M
$-3.9M
Q3 24
$-11.7M
$5.5M
Q2 24
$-32.1M
$1.3M
Q1 24
$-16.7M
$10.1M
FCF Margin
FIP
FIP
HCAT
HCAT
Q4 25
-47.8%
12.9%
Q3 25
-64.5%
-0.9%
Q2 25
-71.6%
-11.4%
Q1 25
-157.7%
-0.5%
Q4 24
-42.4%
-4.9%
Q3 24
-14.0%
7.2%
Q2 24
-37.9%
1.7%
Q1 24
-20.3%
13.5%
Capex Intensity
FIP
FIP
HCAT
HCAT
Q4 25
45.9%
0.4%
Q3 25
47.2%
0.3%
Q2 25
67.3%
0.3%
Q1 25
68.6%
0.8%
Q4 24
32.5%
0.5%
Q3 24
31.1%
0.9%
Q2 24
17.2%
0.4%
Q1 24
15.6%
0.3%
Cash Conversion
FIP
FIP
HCAT
HCAT
Q4 25
Q3 25
Q2 25
Q1 25
-0.71×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FIP
FIP

Power Revenues$45.9M32%
Rail Revenue$44.6M31%
Service Other$22.8M16%
Gas Revenues$15.3M11%
Roadside Services Revenues$11.5M8%
Rapauno$1.2M1%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons